Cellini et al., 2014 - Google Patents
Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapyCellini et al., 2014
View HTML- Document ID
- 7929340624064820820
- Author
- Cellini F
- Morganti A
- Genovesi D
- Silvestris N
- Valentini V
- Publication year
- Publication venue
- Molecules
External Links
Snippet
MicroRNAs (miRNA) are small, non-coding, RNAs with gene expression regulator roles. As an important class of regulators of many cellular pathways, miRNAs are involved in many signaling pathways and DNA damage repair processes, affecting cellular radiosensitivity …
- 229920001239 microRNA 0 title abstract description 207
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
- C12N2320/11—Applications; Uses in screening processes for the determination of target sites, i.e. of active nucleic acids
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/12—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for modelling or simulation in systems biology, e.g. probabilistic or dynamic models, gene-regulatory networks, protein interaction networks or metabolic networks
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/10—Production naturally occurring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cellini et al. | Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy | |
Smolarz et al. | miRNAs in cancer (review of literature) | |
Ali Syeda et al. | Regulatory mechanism of MicroRNA expression in cancer | |
Ding et al. | MicroRNAs involved in carcinogenesis, prognosis, therapeutic resistance, and applications in human triple-negative breast cancer | |
Chan et al. | Noncoding RNA: RNA regulatory networks in cancer | |
Ding et al. | The dual role of microRNAs in colorectal cancer progression | |
Inamura et al. | MicroRNA in lung cancer: novel biomarkers and potential tools for treatment | |
Podralska et al. | Non-coding RNAs in cancer radiosensitivity: MicroRNAs and lncRNAs as regulators of radiation-induced signaling pathways | |
Riquelme et al. | Emerging role of miRNAs in the drug resistance of gastric cancer | |
Bertoli et al. | MicroRNAs as biomarkers for diagnosis, prognosis and theranostics in prostate cancer | |
Lopez-Rincon et al. | Machine learning-based ensemble recursive feature selection of circulating mirnas for cancer tumor classification | |
Palmini et al. | What is new in the miRNA world regarding osteosarcoma and chondrosarcoma? | |
He et al. | MicroRNAs, DNA damage response, and cancer treatment | |
D’Ippolito et al. | MicroRNAs and triple negative breast cancer | |
Huang et al. | Extracellular microRNAs in urologic malignancies: chances and challenges | |
Abba et al. | MicroRNAs in the regulation of MMPs and metastasis | |
Campos-Parra et al. | Micro-RNAs as potential predictors of response to breast cancer systemic therapy: future clinical implications | |
Lopez-Camarillo et al. | MetastamiRs: non-coding microRNAs driving cancer invasion and metastasis | |
Anwar et al. | MicroRNAs: emerging novel clinical biomarkers for hepatocellular carcinomas | |
Llobat et al. | Role of MicroRNAs in human osteosarcoma: future perspectives | |
Cosentino et al. | MicroRNA and oxidative stress interplay in the context of breast cancer pathogenesis | |
Sundarbose et al. | MicroRNAs as biomarkers in cancer | |
Arrighetti et al. | miRNAs as therapeutic tools and biomarkers for prostate cancer | |
Zelli et al. | Circulating microRNAs as prognostic and therapeutic biomarkers in breast cancer molecular subtypes | |
Szatkowska et al. | Regulation of DNA damage response and homologous recombination repair by microRNA in human cells exposed to ionizing radiation |